{"id":48937,"date":"2022-09-28T21:02:36","date_gmt":"2022-09-28T19:02:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/"},"modified":"2022-09-28T21:02:36","modified_gmt":"2022-09-28T19:02:36","slug":"gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/","title":{"rendered":"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates"},"content":{"rendered":"<div>\n<p>\n<i>Expanded access to optimal cancer care for Medi-Cal beneficiaries outlined in the California Cancer Care Equity Act scheduled to take effect Jan. 1, 2023<\/i>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220928005987\/en\/1586159\/5\/Cancer_Care_is_Different.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220928005987\/en\/1586159\/21\/Cancer_Care_is_Different.jpg\"><\/a><\/p>\n<p>SACRAMENTO, Calif.&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fcancercarediff.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Cancer+Care+Is+Different&amp;index=1&amp;md5=f2ad56e810392ec81c945792ab135e3d\" rel=\"nofollow noopener\" shape=\"rect\">Cancer Care Is Different<\/a> (CCID) Coalition today commends Gov. Gavin Newsom for signing the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fleginfo.legislature.ca.gov%2Ffaces%2FbillTextClient.xhtml%3Fbill_id%3D202120220SB987&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=California+Cancer+Care+Equity+Act+%28SB+987%29&amp;index=2&amp;md5=9801be73f19c3f6fe24c56ae3b3ae073\" rel=\"nofollow noopener\" shape=\"rect\">California Cancer Care Equity Act (SB 987)<\/a>, a bill that will expand access to specialized cancer care for Medi-Cal patients who receive a complex cancer diagnosis. The bill was introduced by Sen. Anthony Portantino (SD-25) in April and passed by both chambers of the California Legislature unanimously. SB 987 represents a critical first step in delivering on the promise of the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cancercarediff.org%2Fcancer-patients-bill-of-rights%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=California+Cancer+Patients+Bill+of+Rights&amp;index=3&amp;md5=46fae8e99c263986fa35baa4a96074f0\" rel=\"nofollow noopener\" shape=\"rect\">California Cancer Patients Bill of Rights<\/a> resolution adopted by the Legislature in 2021.\n<\/p>\n<p>\nThe California Cancer Care Equity Act (CCCEA) takes effect January 1, 2023, enabling the most vulnerable populations of California to seek optimal cancer care services more easily, such as genomic testing, precision medicine-based care, subspecialty expertise and clinical trials.\n<\/p>\n<p>\n\u201cThis legislation will make optimal cancer care available to more patients and families in California,\u201d said <b>Robert Stone, CEO of City of Hope and the Helen and Morgan Chu Chief Executive Officer Distinguished Chair<\/b>. \u201cGovernor Newsom is showing the nation how we create a more equitable cancer ecosystem that works better for patients and expands access to lifesaving, leading-edge treatments for those from historically underserved communities. On behalf of cancer patients and their families, we are grateful for Senator Portantino\u2019s leadership on this legislation and look forward to exploring additional solutions to removing unnecessary barriers that keep cancer patients from achieving improved health outcomes.\u201d\n<\/p>\n<p>\nThe CCCEA will help remove barriers that prevent access to leading-edge care for Medi-Cal beneficiaries \u2014 who represent approximately <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dhcs.ca.gov%2Fdataandstats%2FPages%2FMedi-Cal-Eligibility-Statistics.aspx&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=one-third+of+California%26%238217%3Bs+population&amp;index=4&amp;md5=d87fe4b75202db154de287ff05fc7c13\" rel=\"nofollow noopener\" shape=\"rect\">one-third of California\u2019s population<\/a>. At present, patients <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fescholarship.org%2Fuc%2Fitem%2F8xc078vj&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=on+Medi-Cal&amp;index=5&amp;md5=16257ec11d1529f4fa26c34d49a32972\" rel=\"nofollow noopener\" shape=\"rect\">on Medi-Cal<\/a> experience less favorable five-year survival rates for several cancer types compared to patients on private insurance. Notably, African Americans and Hispanics have the highest rates of Medi-Cal enrollment in California at 44.3% and 44.9%, respectively.\n<\/p>\n<p>\n\u201cI am pleased that California will make access to leading-edge cancer treatments available for Medi-Cal patients a reality,\u201d said the bill\u2019s author, <b>Senator Anthony Portantino (SD-25)<\/b>. \u201cWhile there\u2019s more we need to fix in our current delivery system to get the latest innovations to patients equitably or quickly, this is a huge win for patients that will lay the groundwork for additional reforms in the future. With California home to the most prominent and effective research hospitals in the world, we need to make sure that their efforts reach as many people as possible.\u201d\n<\/p>\n<p>\nIn 2022, an estimated 189,000 Californians will receive a cancer diagnosis from their physician. In an age when new treatments like CAR T cell therapies are <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fashpublications.org%2Fblood%2Farticle%2F132%2FSupplement%25201%2F322%2F263817%2FCAR-T-Therapy-Displays-Favorable-Gains-in-Health&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=improving+health+outcomes+while+demonstrating+cost-effectiveness&amp;index=6&amp;md5=b5f61c52fcc6d109d10a86bc2209ccbf\" rel=\"nofollow noopener\" shape=\"rect\">improving health outcomes while demonstrating cost-effectiveness<\/a>, legislation like the CCCEA has the potential to reduce system inefficiencies and drive higher-value care in the long term, simultaneously helping to save the lives of Californians and increasing access to the kind of cancer care any Californian would demand for a loved one fighting cancer.\n<\/p>\n<p>\nThe Cancer Care Is Different coalition is driven by the belief that the best chance of a cure for a patient is the first chance at a cure: Cancer outcomes uniquely rely on the accuracy and speed of initial diagnosis, choice of therapy and access to appropriate clinical trials. SB 987 is one major step that gives us hope that more Californians will be able to access the care that gives each the best chance to beat cancer, regardless of their insurance or zip code.\n<\/p>\n<p>\n\u201cPatients deserve to access specialized care appropriate for their individual cancer, including enrolling in clinical trials and innovative therapies without unnecessary and unfair barriers,\u201d said <b>Autumn J. Ogden-Smith, California legislative director of the American Cancer Society Cancer Action Network. <\/b>\u201cWith the enactment of the California Cancer Care Equity Act, more Medi-Cal patients with cancer will have access to the full range of medical options available for their cancer.\u201d\n<\/p>\n<p>\n\u201cOn behalf of the nearly 32,000 Californians expected to be diagnosed with breast cancer this year alone, we are thrilled with Gov. Newsom\u2019s decision to sign the California Cancer Care Equity Act which will help deliver high-quality treatment and care to more Californians diagnosed with cancer,\u201d said <b>Molly Guthrie, Vice President of Policy &amp; Advocacy for Susan G. Komen.<\/b> \u201cWe are incredibly grateful to the state legislature for their overwhelming support of this bill and look forward to advocating for additional reforms to help ensure equitable access to care for underserved patients in California.\u201d\n<\/p>\n<p>\n\u201cAll patients deserve access to the treatment best suited to their needs \u2014 but historically, in California, they haven\u2019t gotten that,\u201d said <b>Thea Zajac, California advocacy director for The Leukemia &amp; Lymphoma Society<\/b>. \u201cThis landmark reform will enable the healthcare system in California to better serve cancer patients and their families. Our organization is proud to support SB 987 as a crucial step to ensuring that all Californians with cancer can access the lifesaving treatment that\u2019s right for them.\u201d\n<\/p>\n<p>\n<b>About Cancer Care Is Different<\/b>\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cancercarediff.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Cancer+Care+Is+Different&amp;index=7&amp;md5=d1c09153ce6d62d6c67de0444aa63e0e\" rel=\"nofollow noopener\" shape=\"rect\">Cancer Care Is Different<\/a> is a coalition-based campaign effort focused on raising awareness of the need to improve cancer care delivery in California. Partners in this effort include <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cityofhope.org%2Fhomepage&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=City+of+Hope&amp;index=8&amp;md5=f415d53e19d739e07f5af9ea71753dad\" rel=\"nofollow noopener\" shape=\"rect\">City of Hope<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cedars-sinai.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Cedars-Sinai&amp;index=9&amp;md5=52836c8953394ffe036e2df1637aeb70\" rel=\"nofollow noopener\" shape=\"rect\">Cedars-Sinai<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fightcancer.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=American+Cancer+Society+Cancer+Action+Network&amp;index=10&amp;md5=1f0618635a14b1a21affaf205266428a\" rel=\"nofollow noopener\" shape=\"rect\">American Cancer Society Cancer Action Network<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.komen.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Susan+G.+Komen&amp;index=11&amp;md5=60a4919aa93e8949adbc7d0eb1ab267d\" rel=\"nofollow noopener\" shape=\"rect\">Susan G. Komen<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.lls.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=The+Leukemia+%26amp%3B+Lymphoma+Society&amp;index=12&amp;md5=0f6224e588de376bfe5d3d3ea5c3634a\" rel=\"nofollow noopener\" shape=\"rect\">The Leukemia &amp; Lymphoma Society<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbethematch.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=National+Marrow+Donor+Program%2FBe+The+Match&amp;index=13&amp;md5=aa3ad3ef52981c32e4b98108e40ef448\" rel=\"nofollow noopener\" shape=\"rect\">National Marrow Donor Program\/Be The Match<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.californiachroniccare.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=California+Chronic+Care+Coalition&amp;index=14&amp;md5=1461d196141600be3da02102b98f6c9d\" rel=\"nofollow noopener\" shape=\"rect\">California Chronic Care Coalition<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.northbaycancer.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=North+Bay+Cancer+Alliance&amp;index=15&amp;md5=8b049c0a464a30985469a331d082db41\" rel=\"nofollow noopener\" shape=\"rect\">North Bay Cancer Alliance<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Flazarex.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Lazarex+Cancer+Foundation&amp;index=16&amp;md5=a2ec89fbbd7a57b0a844b29f5ec4a345\" rel=\"nofollow noopener\" shape=\"rect\">Lazarex Cancer Foundation<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftriagecancer.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Triage+Cancer&amp;index=17&amp;md5=799c2093a2e787d263eaf835b377c12a\" rel=\"nofollow noopener\" shape=\"rect\">Triage Cancer<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Flatinocancerinstitute.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=The+Latino+Cancer+Institute&amp;index=18&amp;md5=d58869177e7bb6bb5a0c910ad4485871\" rel=\"nofollow noopener\" shape=\"rect\">The Latino Cancer Institute<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cablackhealthnetwork.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=California+Black+Health+Network&amp;index=19&amp;md5=b89ded85e6629377e9fcf6b1b9137906\" rel=\"nofollow noopener\" shape=\"rect\">California Black Health Network<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fstanfordhealthcare.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Stanford+Health+Care&amp;index=20&amp;md5=8bc05692b3abb7d6637b4b853bc77abe\" rel=\"nofollow noopener\" shape=\"rect\">Stanford Health Care<\/a>.\n<\/p>\n<p>\nThe CCID Coalition\u2019s statement announcing support for SB 987 can be found <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cancercarediff.org%2Fsb987pr%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=here&amp;index=21&amp;md5=7ec4e684046c511a3ccb98a29c1803fb\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>. For more information on CCID, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cancercarediff.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=CancerCareDiff.org&amp;index=22&amp;md5=458de0ba5c82df1497ee91b2f6c36b49\" rel=\"nofollow noopener\" shape=\"rect\">CancerCareDiff.org<\/a>.\n<\/p>\n<p>\n<b>About City of Hope<\/b>\n<\/p>\n<p>\nCity of Hope&#8217;s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cityofhope.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=City+of+Hope&amp;index=23&amp;md5=3a468bff0d3cea2ca608a6b7d4c54852\" rel=\"nofollow noopener\" shape=\"rect\">City of Hope<\/a> has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. As an independent, National Cancer Institute-designated comprehensive cancer center, City of Hope brings a uniquely integrated model to patients, spanning cancer care, research and development, academics and training, and innovation initiatives. Research and technology developed at City of Hope has been the basis for <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cityofhope.org%2Fresearch%2Fbeckman-research-institute%2Fabout-beckman-research-institute%2Fbeckman-research-institute-milestones&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=numerous+breakthrough+cancer+medicines&amp;index=24&amp;md5=810d02005509505e28b3aee514eff4c4\" rel=\"nofollow noopener\" shape=\"rect\">numerous breakthrough cancer medicines<\/a>, as well as human synthetic insulin and monoclonal antibodies. A leader in <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cityofhope.org%2Fclinical-program%2Fbone-marrow-and-blood-stem-cell-transplants&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=bone+marrow+transplantation&amp;index=25&amp;md5=69b04dd244b3e44800f5a623dd48f39e\" rel=\"nofollow noopener\" shape=\"rect\">bone marrow transplantation <\/a>and immunotherapy, such as <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cityofhope.org%2Fresearch%2Fcar-t-cell-therapy&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=CAR+T+cell+therapy&amp;index=26&amp;md5=3a6d9318a1b1f0ec985466d7a87ac86d\" rel=\"nofollow noopener\" shape=\"rect\">CAR T cell therapy<\/a>, City of Hope\u2019s personalized treatment protocols help advance cancer care throughout the world.\n<\/p>\n<p>\nWith a goal of expanding access to the latest discoveries and leading-edge care to more patients, families and communities, City of Hope\u2019s growing national system includes its main Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cancercenter.com%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Cancer+Treatment+Centers+of+America&amp;index=27&amp;md5=8b7afefe5a21dc997da32f3ae882fb9f\" rel=\"nofollow noopener\" shape=\"rect\">Cancer Treatment Centers of America<\/a>. City of Hope\u2019s affiliated family of organizations includes <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.tgen.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Translational+Genomics+Research+Institute&amp;index=28&amp;md5=36e7c7c8eabf401d505544737271c462\" rel=\"nofollow noopener\" shape=\"rect\">Translational Genomics Research Institute<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.myaccesshope.org%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=AccessHopeTM&amp;index=29&amp;md5=7e529a5ba58bfa2662564a928cc71a2f\" rel=\"nofollow noopener\" shape=\"rect\">AccessHope<sup>TM<\/sup><\/a>. For more information about City of Hope, follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fcityofhope&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Facebook&amp;index=30&amp;md5=45dc0b01f9c5465bf905e5f09456de17\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fcityofhope&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Twitter&amp;index=31&amp;md5=1af3179b08f089e0aec2cf8cbbc3b68f\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fuser%2Fcityofhopeonline&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=YouTube&amp;index=32&amp;md5=698d895869617bcef320d785216b95dd\" rel=\"nofollow noopener\" shape=\"rect\">YouTube<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fcityofhope%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=Instagram&amp;index=33&amp;md5=85b09348bb5d8f66d71b70eab1613645\" rel=\"nofollow noopener\" shape=\"rect\">Instagram<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fcity-of-hope%2F&amp;esheet=52929440&amp;newsitemid=20220928005987&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=34&amp;md5=e77e5991d3b423702e7aa085217f9d55\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nLetisia Marquez<br \/>\n<br \/>626-476-7593<br \/>\n<br \/><a target=\"_blank\" href=\"mai&#108;&#116;&#111;&#58;&#x6c;&#x65;&#x6d;&#x61;&#x72;&#x71;&#x75;ez&#64;&#99;&#111;&#104;&#46;&#111;&#x72;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6c;&#x65;&#109;a&#x72;&#x71;&#117;&#101;z&#x40;&#x63;&#111;&#104;&#46;&#x6f;&#x72;&#103;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Expanded access to optimal cancer care for Medi-Cal beneficiaries outlined in the California Cancer Care Equity Act scheduled to take effect Jan. 1, 2023 SACRAMENTO, Calif.&#8211;(BUSINESS WIRE)&#8211;The Cancer Care Is Different (CCID) Coalition today commends Gov. Gavin Newsom for signing the California Cancer Care Equity Act (SB 987), a bill that will expand access to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48937","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Expanded access to optimal cancer care for Medi-Cal beneficiaries outlined in the California Cancer Care Equity Act scheduled to take effect Jan. 1, 2023 SACRAMENTO, Calif.&#8211;(BUSINESS WIRE)&#8211;The Cancer Care Is Different (CCID) Coalition today commends Gov. Gavin Newsom for signing the California Cancer Care Equity Act (SB 987), a bill that will expand access to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-28T19:02:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220928005987\/en\/1586159\/21\/Cancer_Care_is_Different.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates\",\"datePublished\":\"2022-09-28T19:02:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/\"},\"wordCount\":1166,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005987\\\/en\\\/1586159\\\/21\\\/Cancer_Care_is_Different.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/\",\"name\":\"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005987\\\/en\\\/1586159\\\/21\\\/Cancer_Care_is_Different.jpg\",\"datePublished\":\"2022-09-28T19:02:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005987\\\/en\\\/1586159\\\/21\\\/Cancer_Care_is_Different.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005987\\\/en\\\/1586159\\\/21\\\/Cancer_Care_is_Different.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/","og_locale":"en_US","og_type":"article","og_title":"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates - Pharma Trend","og_description":"Expanded access to optimal cancer care for Medi-Cal beneficiaries outlined in the California Cancer Care Equity Act scheduled to take effect Jan. 1, 2023 SACRAMENTO, Calif.&#8211;(BUSINESS WIRE)&#8211;The Cancer Care Is Different (CCID) Coalition today commends Gov. Gavin Newsom for signing the California Cancer Care Equity Act (SB 987), a bill that will expand access to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-28T19:02:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220928005987\/en\/1586159\/21\/Cancer_Care_is_Different.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates","datePublished":"2022-09-28T19:02:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/"},"wordCount":1166,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220928005987\/en\/1586159\/21\/Cancer_Care_is_Different.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/","url":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/","name":"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220928005987\/en\/1586159\/21\/Cancer_Care_is_Different.jpg","datePublished":"2022-09-28T19:02:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220928005987\/en\/1586159\/21\/Cancer_Care_is_Different.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220928005987\/en\/1586159\/21\/Cancer_Care_is_Different.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/gov-newsom-signs-landmark-cancer-access-legislation-into-law-california-cancer-coalition-celebrates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48937"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48937\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}